Description
Recombinant monoclonal antibody to HLA-DR. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma L243. This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2 format for improved compatibility with existing reagents assays and techniques.
Target
HLA-DR
Target Alias Names
CD74, HLA class II histocompatibility antigen gamma chain, HLA-DR antigens-associated invariant chain, Ia antigen-associated invariant chain, Ii, p33
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression